Last updated: 14 October 2020 at 4:19pm EST

Daniel C Md Adelman Net Worth




The estimated Net Worth of Daniel C Md Adelman is at least $339 Thousand dollars as of 2 October 2020. Daniel Adelman owns over 34,932 units of Sunesis Pharmaceuticals Inc stock worth over $339,453 and over the last 19 years Daniel sold SNSS stock worth over $0.

Daniel Adelman SNSS stock SEC Form 4 insiders trading

Daniel has made over 7 trades of the Sunesis Pharmaceuticals Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Daniel exercised 34,932 units of SNSS stock worth $399,971 on 2 October 2020.

The largest trade Daniel's ever made was exercising 36,717 units of Sunesis Pharmaceuticals Inc stock on 12 January 2018 worth over $420,410. On average, Daniel trades about 6,747 units every 55 days since 2005. As of 2 October 2020 Daniel still owns at least 63,807 units of Sunesis Pharmaceuticals Inc stock.

You can see the complete history of Daniel Adelman stock trades at the bottom of the page.



What's Daniel Adelman's mailing address?

Daniel's mailing address filed with the SEC is 8000 Marina Blvd #200, Brisbane, CA 94005, USA.

Insiders trading at Sunesis Pharmaceuticals Inc

Over the last 19 years, insiders at Sunesis Pharmaceuticals Inc have traded over $89,557,714 worth of Sunesis Pharmaceuticals Inc stock and bought 191,253,594 units worth $84,730,221 . The most active insiders traders include Forest Baskett, Scott D Sandell, and Peter J Barris. On average, Sunesis Pharmaceuticals Inc executives and independent directors trade stock every 67 days with the average trade being worth of $14,060,191. The most recent stock trade was executed by Tina Gullotta on 29 May 2020, trading 6,000 units of SNSS stock currently worth $1,980.





What does Sunesis Pharmaceuticals Inc's logo look like?

Sunesis Pharmaceuticals Inc logo

Complete history of Daniel Adelman stock trades at Aimmune Therapeutics Inc and Sunesis Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
2 Oct 2020 Daniel C Md Adelman
Chief Medical Officer
Option 34,932 $11.45 $399,971
2 Oct 2020
63,807
2 Jan 2020 Daniel C Md Adelman
Chief Medical Officer
Option 20,000 $19.63 $392,600
2 Jan 2020
41,250
9 Dec 2019 Daniel C Md Adelman
Chief Medical Officer
Option 20,000 $11.45 $229,000
9 Dec 2019
41,250
12 Jan 2018 Daniel C Md Adelman
Chief Medical Officer
Option 36,717 $11.45 $420,410
12 Jan 2018
9,933
27 Dec 2017 Daniel C Md Adelman
Chief Medical Officer
Option 3,283 $11.45 $37,590
27 Dec 2017
3,283
23 Oct 2017 Daniel C Md Adelman
Chief Medical Officer
Option 10,000 $11.45 $114,500
23 Oct 2017
10,000
25 Sep 2017 Daniel C Md Adelman
Chief Medical Officer
Option 10,000 $11.45 $114,500
25 Sep 2017
10,000


Sunesis Pharmaceuticals Inc executives and stock owners

Sunesis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: